Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

51.37 -0.68 (-1.31%)
Official Closing Price Updated: 7:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,478,163
Open 52.67
Bid (Size) 51.36 (7)
Ask (Size) 51.39 (4)
Prev. Close 52.05
Today's Range 51.19 - 52.80
52wk Range 45.05 - 113.76
Shares Outstanding N/A
Dividend Yield 4.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner
It offers compelling weight-loss drugs -- and a compelling stock price, too. 
Via The Motley Fool
Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried?
It's not the end of the world for the drugmaker. 
Via The Motley Fool
Topics Government Intellectual Property

Performance

YTD
-41.3%
-41.3%
1 Month
-7.4%
-7.4%
3 Month
+2.7%
+2.7%
6 Month
-22.7%
-22.7%
1 Year
-54.1%
-54.1%

More News

Read More
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
Via The Motley Fool
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
P/E Ratio Insights for Novo Nordisk
Via Benzinga
What Is 1 of the Best Pharmaceutical Stocks to Buy Now?
Via The Motley Fool
Viking Therapeutics: High Risk, High Reward Play
Via MarketBeat
Options Corner: A Reliable Quant Signal Just Flashed Again For Pharma Giant Novo Nordisk
Via Benzinga
Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership
Via Benzinga
Topics Initial Public Offering
Breakout Momentum Plays You Need to Know About
Via MarketBeat
Weight Loss Drugs Are Quietly Exploding Employer Health Insurance Costs: 'There Is A Quiet Alarm Bell Going Off'
Via Benzinga
Marjorie Taylor Greene Buys 6 Stocks And Bitcoin ETF: Here's Her Latest Shopping List
Via Benzinga
Novo Nordisk Shares Tumble Amid Sweeping Board Overhaul
Via MarketMinute
Topics Economy Government Intellectual Property
3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report
Via The Motley Fool
Topics Intellectual Property
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
Via The Motley Fool
Topics Government
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
Via The Motley Fool
Behind the Scenes of Novo Nordisk's Latest Options Trends
Via Benzinga
2 Beaten-Down Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond
Via The Motley Fool
'No Place Is Risk-Free Until The World Is Polio-Free:' Bill Gates Urges Global Action To Close Deadly Immunity Gaps
Via Benzinga
Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks
Via Benzinga
Topics World Trade
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet
Via Benzinga
Topics ETFs Government
Trump-Induced Volatility Aside, Novo Trades Cheap While Patents Protect Its Profits Until 2032
Via Benzinga
Topics Government Intellectual Property
Novo Nordisk Stock Is Falling Friday: What's Driving The Action?
Via Benzinga
Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.
Via Investor's Business Daily
Topics Government

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 51.37
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/29/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.